(RTTNews) – Progenity Inc.(PROG) shares are more than 8% or $0.63 above Monday morning’s share at $8.34, even though the biotech company reported a larger loss at the time of the quarter.
On Friday, Progenity reported that its second-quarter net loss attributable to non-unusual shareholders was extended to $53.05 million or $6.11 according to the stock, from $16.41 million or $3.34 according to the stock.’last year. Revenues for the quarter fell to $17.27 million from $57.23 million a year earlier.
Progenity also said that its affiliated lab, Avero Diagnostics, which offers molecular control of infectious diseases, has introduced COVID-19 molecular control to satisfy widespread unsatisfied desires in the southeastern United States, and is comparing opportunities to offer coVID-19 molecular.more widely check across the country.
Progenity has listed between $7.63 and $15.92 over the more than 52 weeks.